project id: TCGA-MESO; case submitter id: TCGA-MQ-A4LC; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.94; rna integrity number: 7.3; age at index: 54; days to birth: -19866; days to death: 2790; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1947; year of death: 2008; age at diagnosis: 19866; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2001; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; initial weight: 470.0; sample id: c28dcbf0-ef51-4425-b369-0eedd7ffb7d2; sample submitter id: TCGA-MQ-A4LC-01A; portion id: 8badabd0-f255-4353-b2a7-21f92962ad44; portion submitter id: TCGA-MQ-A4LC-01A-31; slide id: 7adde7b8-272f-4872-a7db-99a337d93593; slide submitter id: TCGA-MQ-A4LC-01A-03-TSC; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 85.0; percent tumor cells: 15.0; percent tumor nuclei: 60.0; section location: TOP;